Cambria Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$502K Buy
6,411
+41
+0.6% +$3.31K 0.02% 512
2026
Q1
$552K Buy
6,370
+3,236
+103% +$310K 0.03% 416
2025
Q4
$301K Buy
+3,134
New +$304K 0.02% 503

Other funds holding MDT

Cambria Investment Management's MDT Position: Q2 2026 in Review

Cambria Investment Management increased its Medtronic (MDT) stake by 0.64% in Q2 2026, buying an estimated $3.31K and bringing the position to 6,411 shares worth $502K. The position accounts for 0.02% of the portfolio, ranked #512.

Cambria Investment Management first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $552K in Q1 2026. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Cambria Investment Management held 6,411 shares of Medtronic worth $502K as of Q2 2026.
  • Cambria Investment Management bought 41 Medtronic shares in Q2 2026, an estimated $3.31K.
  • Medtronic made up 0.02% of Cambria Investment Management's portfolio in Q2 2026, its #512 holding.
  • Cambria Investment Management first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Cambria Investment Management's Medtronic position peaked at $552K in Q1 2026.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.